Keywords: Alzheimer's Disease, Alzheimer's Disease, animal model, 13C HP MRIAlzheimer’s disease (AD) is devastating and progressive disease. The non-invasive detection of early onset AD along with the mechanisms that drive its progression are still limited. Recent work has implicated metabolic reprogramming as an earlier AD potential indicator. Therefore, we investigated an AD mouse model at the early stage of development with the goal to evaluate whether co-hyperpolarized [1-13C]pyruvate and [1-13C]dehydroascorbate (DHA) along with 3D MRSI might provide insights into the brain metabolism of FAD mice at the onset of the disease. The metabolism of these translatable biomarkers would then give insight on our understanding of AD diagnosis and treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords